Absence of the RET+3:T allele in the MTC patients

The mutations of the RET proto-oncogene contributes to the development of MTC by increasing the activity of the receptor encoded by this gene. Variant T of polymorphism rs2435357 located in the enhancer of the RET gene reduces the enhancer’s activity. The opposite effects of rs2435357 and the mutati...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Borun, Pawel, Jerzy, Sowinski, Ziemnicka, Katarzyna, Kubaszewski, Lukasz, Lipinski, Daniel, Plawski, Andrzej
Aineistotyyppi: Online Artikkeli Teksti
Kieli:English
Julkaistu: BioMed Central 2012
Aiheet:
Letter to the Editor
Linkit:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533580/
https://www.ncbi.nlm.nih.gov/pubmed/23088776
http://dx.doi.org/10.1186/1897-4287-10-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533580/
https://www.ncbi.nlm.nih.gov/pubmed/23088776
http://dx.doi.org/10.1186/1897-4287-10-14

Samankaltaisia teoksia